[Anti-CD19 chimeric antigen receptors T cells for treatment of relapsed or refractory E2A-PBX1 positive acute lymphoblastic leukemia: three cases report and literatures review]
Zhonghua Xue Ye Xue Za Zhi. 2018 Jan 14;39(1):47-49.
doi: 10.3760/cma.j.issn.0253-2727.2018.01.010.